These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6402015)

  • 1. The in vitro and in vivo inactivation of ribosomes by virginiamycin M does not entail an alteration of 5, 16 and 23 S ribosomal RNA.
    Cocito C; Vanlinden F; Branlant C
    Biochim Biophys Acta; 1983 Mar; 739(2):158-63. PubMed ID: 6402015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lasting ribosome alteration produced by virginiamycin M disappears upon removal of certain ribosomal proteins.
    Moureau P; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1983 Mar; 739(2):164-72. PubMed ID: 6402016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lasting damage to bacterial ribosomes by reversibly bound virginiamycin M.
    Parfait R; Cocito C
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5492-6. PubMed ID: 6776538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of fluorescence quenching of ribosome-bound virginiamycin S.
    Di Giambattista M; Ide G; Engelborghs Y; Cocito C
    J Biol Chem; 1984 May; 259(10):6334-9. PubMed ID: 6427212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of rRNA bases in the interaction of peptidyltransferase inhibitors with bacterial ribosomes.
    Vannuffel P; Di Giambattista M; Cocito C
    J Biol Chem; 1992 Aug; 267(23):16114-20. PubMed ID: 1644798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism of action of virginiamycin-like antibiotics (synergimycins) on protein synthesis in bacterial cell-free systems.
    Cocito C; Chinali G
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():35-52. PubMed ID: 3932310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical probing of a virginiamycin M-promoted conformational change of the peptidyl-transferase domain.
    Vannuffel P; Di Giambattista M; Cocito C
    Nucleic Acids Res; 1994 Oct; 22(21):4449-53. PubMed ID: 7971275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of virginiamycin M on the stability of different ribosomal complexes to ultracentrifugation.
    Chinali G; Vanlinden F; Cocito C
    Biochim Biophys Acta; 1988 May; 950(1):67-74. PubMed ID: 3129013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of ribosomal particles in virginiamycin sensitive and resistant mutants of Bacillus subtilis.
    Cocito C
    Biochimie; 1973; 55(2):153-61. PubMed ID: 4198188
    [No Abstract]   [Full Text] [Related]  

  • 10. Affinity labeling of the virginiamycin S binding site on bacterial ribosome.
    Di Giambattista M; Nyssen E; Pecher A; Cocito C
    Biochemistry; 1990 Oct; 29(39):9203-11. PubMed ID: 2125475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competition between erythromycin and virginiamycin for in vitro binding to the large ribosomal subunit.
    Parfait R; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1981 Jul; 654(2):236-41. PubMed ID: 6793070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis of the inhibitory activities of type A and type B synergimycins and related antibiotics on ribosomes.
    Di Giambattista M; Chinali G; Cocito C
    J Antimicrob Chemother; 1989 Oct; 24(4):485-507. PubMed ID: 2515187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the reversible binding of virginiamycin M to ribosome and particle functions after removal of the antibiotic.
    Nyssen E; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1989 Sep; 1009(1):39-46. PubMed ID: 2506929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence stopped flow analysis of the interaction of virginiamycin components and erythromycin with bacterial ribosomes.
    Moureau P; Engelborghs Y; Di Giambattista M; Cocito C
    J Biol Chem; 1983 Dec; 258(23):14233-8. PubMed ID: 6417137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of erythromycin and virginiamycin S on polypeptide synthesis in cell-free systems.
    Chinali G; Nyssen E; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1988 Nov; 951(1):42-52. PubMed ID: 3142522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary structure features of ribosomal RNA species within intact ribosomal subunits and efficiency of RNA-protein interactions in thermoacidophilic (Caldariella acidophila, Bacillus acidocaldarius) and mesophilic (Escherichia coli) bacteria.
    Cammarano P; Mazzei F; Londei P; Teichner A; de Rosa M; Gambacorta A
    Biochim Biophys Acta; 1983 Aug; 740(3):300-12. PubMed ID: 6347258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro binding of virginiamycin M to bacteria ribosomes and ribosomal subunits.
    Cocito C; Di Giambattista M
    Mol Gen Genet; 1978 Oct; 166(1):53-9. PubMed ID: 105240
    [No Abstract]   [Full Text] [Related]  

  • 18. Topography of 5.8 S rRNA in rat liver ribosomes. Identification of diethyl pyrocarbonate-reactive sites.
    Lo AC; Nazar RN
    J Biol Chem; 1982 Apr; 257(7):3516-24. PubMed ID: 7061495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A spectrofluorimetric study of the interaction between virginiamycin S and bacterial ribosomes.
    Parfait R; de Béthune MP; Cocito C
    Mol Gen Genet; 1978 Oct; 166(1):45-51. PubMed ID: 105239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ribosomal cycle in bacteria treated with an inhibitor of protein synthesis.
    Cocito C
    Biochimie; 1973; 55(3):309-16. PubMed ID: 4200739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.